US Patent 8518919 Compositions comprising azelastine and methods of use thereof
Patent 8518919 was granted and assigned to Meda Pharmaceuticals on August, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 29 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 7 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 5 Jul, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08518919 Compositions comprising azelastine and methods of use thereof US Patent 8518919 Compositions comprising azelastine and methods of use thereof
Infobox
Patent Number
085189190
Patent Number
85189190
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
085189190
Date of Patent
August 27, 2013
0Patent Application Number
132940690
Date Filed
November 10, 2011
0Patent Primary Examiner
Edits on 17 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08518919 Compositions comprising azelastine and methods of use thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08518919
Date of patent
August 27, 2013
Patent application number
13294069
Date Filed
November 10, 2011
Patent primary examiner
Find more entities like US Patent 8518919 Compositions comprising azelastine and methods of use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
